Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

被引：0
|
作者：
Bee Kim Tan
Siew Siang Chua
Li-Chia Chen
Kian Meng Chang
Sharmini Balashanker
Ping Chong Bee
机构：
[1] Jalan Universiti,Department of Medicine, Faculty of Medicine, University of Malaya
[2] Taylor’s University,School of Pharmacy, Faculty of Health and Medical Sciences
[3] University of Manchester,Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health
[4] Manchester Academic Health Science Centre,Department of Hematology
[5] Ampang Hospital,School of Pharmacy
[6] Ministry of Health Malaysia,undefined
[7] University of Nottingham Malaysia Campus,undefined
来源：
Supportive Care in Cancer | 2020年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Revised Funding Information.
引用
收藏
页码：3249 / 3249
相关论文
共 50 条
  • [1] Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial
    Bee Kim Tan
    Siew Siang Chua
    Li-Chia Chen
    Kian Meng Chang
    Sharmini Balashanker
    Ping Chong Bee
    Supportive Care in Cancer, 2020, 28 : 3237 - 3247
  • [2] Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial (vol 28, pg 3237, 2020)
    Tan, Bee Kim
    Chua, Siew Siang
    Chen, Li-Chia
    Chang, Kian Meng
    Balashanker, Sharmini
    Bee, Ping Chong
    SUPPORTIVE CARE IN CANCER, 2020, 28 (07) : 3249 - 3249
  • [3] Adherence assessment in Chronic Myeloid Leukaemia patients treated by tyrosine kinase inhibitors
    Daouphars, M.
    Ouvry, M.
    Lenain, P.
    Rouvet, J.
    Varin, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 414 - 415
  • [4] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Anna Rychter
    Piotr Jerzmanowski
    Adam Hołub
    Zofia Specht-Szwoch
    Violetta Kalinowska
    Urszula Tęgowska
    Ilona Seferyńska
    Agnieszka Kołkowska-Leśniak
    Ewa Lech-Marańda
    Joanna Góra-Tybor
    Medical Oncology, 2017, 34
  • [5] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Rychter, Anna
    Jerzmanowski, Piotr
    Holub, Adam
    Specht-Szwoch, Zofia
    Kalinowska, Violetta
    Tegowska, Urszula
    Seferynska, Ilona
    Kolkowska-Lesniak, Agnieszka
    Lech-Maranda, Ewa
    Gora-Tybor, Joanna
    MEDICAL ONCOLOGY, 2017, 34 (06)
  • [6] Adverse outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Papaila, Alexa
    Godding, Mark
    Liu, Michael
    HEART, 2021, 107 (20) : 1680 - 1680
  • [7] Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia
    Garcia, Betel Del Rosario
    Romero, Maria Micaela Vina
    Rosa, Virginia Gonzalez
    Payer, Carolina Alarcon
    Oliva, Leonor Oliva
    Merino Alonso, Francisco Javier Merino
    Casariego, Gloria Julia Nazco
    Nicolas, Fernando Gutierrez
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (05) : 902 - 906
  • [8] Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia
    Cheng, Fang
    Cui, Zheng
    Li, Qiang
    Wang, Liu
    Li, Weiming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [9] Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan
    Tsai, Yu-Fen
    Huang, Wen-Chuan
    Cho, Shih-Feng
    Hsiao, Hui-Hua
    Liu, Yi-Chang
    Lin, Sheng-Fung
    Liu, Ta-Chih
    Chang, Chao-Sung
    MEDICINE, 2018, 97 (26)
  • [10] Improving medication adherence in patients with hypertension: a randomised controlled trial
    Hedegaard, U.
    Kjeldsen, L. J.
    Pottegard, A.
    Henriksen, J. E.
    Lambrechtsen, J.
    Hangaard, J.
    Hallas, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 470 - 471
12345